236 related articles for article (PubMed ID: 33293522)
1. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.
Biswas K; Lipton GB; Stauffer S; Sullivan T; Cleveland L; Southon E; Reid S; Magidson V; Iversen ES; Sharan SK
NPJ Genom Med; 2020 Dec; 5(1):52. PubMed ID: 33293522
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
[TBL] [Abstract][Full Text] [Related]
3. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
Iversen ES; Lipton G; Hart SN; Lee KY; Hu C; Polley EC; Pesaran T; Yussuf A; LaDuca H; Chao E; Karam R; Goldgar DE; Couch FJ; Monteiro ANA
NPJ Genom Med; 2022 Jun; 7(1):35. PubMed ID: 35665744
[TBL] [Abstract][Full Text] [Related]
4. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs.
Biswas K; Mitrophanov AY; Sahu S; Sullivan T; Southon E; Nousome D; Reid S; Narula S; Smolen J; Sengupta T; Riedel-Topper M; Kapoor M; Babbar A; Stauffer S; Cleveland L; Tandon M; Malys T; Sharan SK
Cell Rep Methods; 2023 Nov; 3(11):100628. PubMed ID: 37922907
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
[TBL] [Abstract][Full Text] [Related] 
